{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:41:34Z","timestamp":1794411694176,"version":"4.9.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T00:00:00Z","timestamp":1535414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T00:00:00Z","timestamp":1535414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Peritoneal metastasis is a primary metastatic route for gastric cancers, and the mechanisms underlying this process are still unclear. Peritoneal mesothelial cells (PMCs) undergo mesothelial-to-mesenchymal transition (MMT) to provide a favorable environment for metastatic cancer cells. In this study, we investigated how the exosomal miR-21-5p induces MMT and promotes peritoneal metastasis. Gastric cancer (GC)-derived exosomes were identified by transmission electron microscopy and western blot analysis, then the uptake of exosomes was confirmed by PKH-67 staining. The expression of miR-21-5p and SMAD7 were measured by quantitative real-time polymerase chain reaction (qRT-PCR) and western blot, and the interactions between miR-21-5p and its target genes SMAD7 were confirmed by Luciferase reporter assays. The MMT of PMCs was determined by invasion assays, adhesion assays, immunofluorescent assay, and western blot. Meanwhile, mouse model of tumor peritoneal dissemination model was performed to investigate the role of exosomal miR-21-5p in peritoneal metastasis in vivo. We found that PMCs could internalize GC-derived exosomal miR-21-5p and led to increased levels of miR-21-5p in PMCs. Through various types of in vitro and in vivo assays, we confirmed that exosomal miR-21-5p was able to induce MMT of PMCs and promote tumor peritoneal metastasis. Moreover, our study revealed that this process was promoted by exosomal miR-21-5p through activating TGF-\u03b2\/Smad pathway via targeting SMAD7. Altogether, our data suggest that exosomal miR-21-5p induces MMT of PMCs and promote cancer peritoneal dissemination by targeting SMAD7. The exosomal miR-21-5p may be a novel therapeutic target for GC peritoneal metastasis.<\/jats:p>","DOI":"10.1038\/s41419-018-0928-8","type":"journal-article","created":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T13:22:15Z","timestamp":1535462535000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":182,"title":["Exosomal miR-21-5p derived from gastric cancer promotes peritoneal metastasis via mesothelial-to-mesenchymal transition"],"prefix":"10.1038","volume":"9","author":[{"given":"Qiang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwen","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diancai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5179-4128","authenticated-orcid":false,"given":"Zekuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,28]]},"reference":[{"key":"928_CR1","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.6004\/jnccn.2016.0137","volume":"14","author":"JA Ajani","year":"2016","unstructured":"Ajani, J. A. et al. Gastric cancer, version 3.2016, NCCN clinical practice guidelines in oncology. J. Natl. Compr. Canc. Netw. 14, 1286\u20131312 (2016).","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"928_CR2","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1016\/S0140-6736(16)32226-7","volume":"388","author":"L Zong","year":"2016","unstructured":"Zong, L., Abe, M., Seto, Y. & Ji, J. The challenge of screening for early gastric cancer in China. Lancet 388, 2606 (2016).","journal-title":"Lancet"},{"key":"928_CR3","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1016\/S1470-2045(14)70481-4","volume":"16","author":"R Herrero","year":"2015","unstructured":"Herrero, R., Gonzalez, P. & Markowitz, L. E. Present status of human papillomavirus vaccine development and implementation. Lancet Oncol. 16, e206\u2013e216 (2015).","journal-title":"Lancet Oncol."},{"key":"928_CR4","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.ejso.2010.09.006","volume":"36","author":"Y Yonemura","year":"2010","unstructured":"Yonemura, Y. et al. Surgical treatment for peritoneal carcinomatosis from gastric cancer. Eur. J. Surg. Oncol. 36, 1131\u20131138 (2010).","journal-title":"Eur. J. Surg. Oncol."},{"key":"928_CR5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa020809","volume":"348","author":"M Yanez-Mo","year":"2003","unstructured":"Yanez-Mo, M. et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N. Engl. J. Med. 348, 403\u2013413 (2003).","journal-title":"N. Engl. J. Med."},{"key":"928_CR6","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/path.4281","volume":"231","author":"P Sandoval","year":"2013","unstructured":"Sandoval, P. et al. Carcinoma-associated fibroblasts derive from mesothelial cells via mesothelial-to-mesenchymal transition in peritoneal metastasis. J. Pathol. 231, 517\u2013531 (2013).","journal-title":"J. Pathol."},{"key":"928_CR7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ygyno.2015.08.010","volume":"139","author":"M Nakamura","year":"2015","unstructured":"Nakamura, M. et al. Hepatocyte growth factor secreted by ovarian cancer cells stimulates peritoneal implantation via the mesothelial-mesenchymal transition of the peritoneum. Gynecol. Oncol. 139, 345\u2013354 (2015).","journal-title":"Gynecol. Oncol."},{"key":"928_CR8","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.1172\/JCI74778","volume":"124","author":"HA Kenny","year":"2014","unstructured":"Kenny, H. A. et al. Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion. J. Clin. Invest. 124, 4614\u20134628 (2014).","journal-title":"J. Clin. Invest."},{"key":"928_CR9","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/path.4889","volume":"242","author":"A Rynne-Vidal","year":"2017","unstructured":"Rynne-Vidal, A. et al. Mesothelial-to-mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer. J. Pathol. 242, 140\u2013151 (2017).","journal-title":"J. Pathol."},{"key":"928_CR10","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1038\/labinvest.2010.111","volume":"90","author":"P Sandoval","year":"2010","unstructured":"Sandoval, P. et al. PPAR-gamma agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage. Lab. Invest. 90, 1517\u20131532 (2010).","journal-title":"Lab. Invest."},{"key":"928_CR11","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1054\/bjoc.1999.1068","volume":"82","author":"DG Jayne","year":"2000","unstructured":"Jayne, D. G., Perry, S. L., Morrison, E., Farmery, S. M. & Guillou, P. J. Activated mesothelial cells produce heparin-binding growth factors: implications for tumour metastases. Br. J. Cancer 82, 1233\u20131238 (2000).","journal-title":"Br. J. Cancer"},{"key":"928_CR12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0022-4804(03)00307-X","volume":"115","author":"A Sako","year":"2003","unstructured":"Sako, A. et al. Vascular endothelial growth factor synthesis by human omental mesothelial cells is augmented by fibroblast growth factor-2: possible role of mesothelial cell on the development of peritoneal metastasis. J. Surg. Res. 115, 113\u2013120 (2003).","journal-title":"J. Surg. Res."},{"key":"928_CR13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0005-2736(81)90512-5","volume":"645","author":"EG Trams","year":"1981","unstructured":"Trams, E. G., Lauter, C. J., Salem, N. Jr & Heine, U. Exfoliation of membrane ecto-enzymes in the form of micro-vesicles. Biochim. Biophys. Acta 645, 63\u201370 (1981).","journal-title":"Biochim. Biophys. Acta"},{"key":"928_CR14","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.ccell.2016.10.009","volume":"30","author":"A Becker","year":"2016","unstructured":"Becker, A. et al. Extracellular vesicles in cancer: cell-to-cell mediators of metastasis. Cancer Cell. 30, 836\u2013848 (2016).","journal-title":"Cancer Cell."},{"key":"928_CR15","doi-asserted-by":"crossref","first-page":"10963","DOI":"10.1074\/jbc.M207550200","volume":"278","author":"R Wubbolts","year":"2003","unstructured":"Wubbolts, R. et al. Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. J. Biol. Chem. 278, 10963\u201310972 (2003).","journal-title":"J. Biol. Chem."},{"key":"928_CR16","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1002\/1873-3468.12722","volume":"591","author":"G Deng","year":"2017","unstructured":"Deng, G. et al. Gastric cancer-derived exosomes promote peritoneal metastasis by destroying the mesothelial barrier. FEBS Lett. 591, 2167\u20132179 (2017).","journal-title":"FEBS Lett."},{"key":"928_CR17","doi-asserted-by":"crossref","first-page":"e0130472","DOI":"10.1371\/journal.pone.0130472","volume":"10","author":"M Tokuhisa","year":"2015","unstructured":"Tokuhisa, M. et al. Exosomal miRNAs from peritoneum lavage fluid as potential prognostic biomarkers of peritoneal metastasis in gastric cancer. PLoS ONE 10, e0130472 (2015).","journal-title":"PLoS ONE"},{"key":"928_CR18","doi-asserted-by":"crossref","first-page":"D1241","DOI":"10.1093\/nar\/gkr828","volume":"40","author":"S Mathivanan","year":"2012","unstructured":"Mathivanan, S., Fahner, C. J., Reid, G. E. & Simpson, R. J. ExoCarta 2012: database of exosomal proteins, RNA and lipids. Nucleic Acids Res. 40, D1241\u2013D1244 (2012).","journal-title":"Nucleic Acids Res."},{"key":"928_CR19","doi-asserted-by":"crossref","first-page":"5238","DOI":"10.1158\/0008-5472.CAN-04-3804","volume":"65","author":"R Gastpar","year":"2005","unstructured":"Gastpar, R. et al. Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells. Cancer Res. 65, 5238\u20135247 (2005).","journal-title":"Cancer Res."},{"key":"928_CR20","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1596","volume":"9","author":"H Valadi","year":"2007","unstructured":"Valadi, H. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654\u2013659 (2007).","journal-title":"Nat. Cell Biol."},{"key":"928_CR21","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.3892\/ijo.2016.3453","volume":"48","author":"J Liao","year":"2016","unstructured":"Liao, J., Liu, R., Shi, Y. J., Yin, L. H. & Pu, Y. P. Exosome-shuttling microRNA-21 promotes cell migration and invasion-targeting PDCD4 in esophageal cancer. Int. J. Oncol. 48, 2567\u20132579 (2016).","journal-title":"Int. J. Oncol."},{"key":"928_CR22","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1158\/0008-5472.CAN-15-1625","volume":"76","author":"L Li","year":"2016","unstructured":"Li, L. et al. Exosomes derived from hypoxic oral squamous cell carcinoma cells deliver miR-21 to normoxic cells to elicit a prometastatic phenotype. Cancer Res. 76, 1770\u20131780 (2016).","journal-title":"Cancer Res."},{"key":"928_CR23","doi-asserted-by":"crossref","first-page":"101042831769501","DOI":"10.1177\/1010428317695012","volume":"39","author":"J Ren","year":"2017","unstructured":"Ren, J. et al. Characterization of exosomal RNAs derived from human gastric cancer cells by deep sequencing. Tumour Biol. 39, 1010428317695012 (2017).","journal-title":"Tumour Biol."},{"key":"928_CR24","doi-asserted-by":"crossref","first-page":"5162","DOI":"10.1038\/onc.2012.11","volume":"31","author":"AL Smith","year":"2012","unstructured":"Smith, A. L. et al. The miR-106b-25 cluster targets Smad7, activates TGF-beta signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer. Oncogene 31, 5162\u20135171 (2012).","journal-title":"Oncogene"},{"key":"928_CR25","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1158\/1541-7786.MCR-07-0294","volume":"6","author":"TV Do","year":"2008","unstructured":"Do, T. V., Kubba, L. A., Du, H., Sturgis, C. D. & Woodruff, T. K. Transforming growth factor-beta1, transforming growth factor-beta2, and transforming growth factor-beta3 enhance ovarian cancer metastatic potential by inducing a Smad3-dependent epithelial-to-mesenchymal transition. Mol. Cancer Res. 6, 695\u2013705 (2008).","journal-title":"Mol. Cancer Res."},{"key":"928_CR26","volume":"3","author":"Q Li","year":"2013","unstructured":"Li, Q. et al. MiR-21\/Smad 7 signaling determines TGF-beta1-induced CAF formation. Sci. Rep. 3, 2038 (2013).","journal-title":"Sci. Rep."},{"key":"928_CR27","first-page":"98","volume":"8","author":"S Paget","year":"1989","unstructured":"Paget, S. The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastas. Rev. 8, 98\u2013101 (1989).","journal-title":"Cancer Metastas. Rev."},{"key":"928_CR28","doi-asserted-by":"crossref","unstructured":"Rynne-Vidal, A. et al. The mesothelial origin of carcinoma associated-fibroblasts in peritoneal metastasis. Cancers, 7, 1994\u20132011 (2015).","DOI":"10.3390\/cancers7040872"},{"key":"928_CR29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11010-013-1583-0","volume":"377","author":"ZD Lv","year":"2013","unstructured":"Lv, Z. D. et al. Mesothelial cells differentiate into fibroblast-like cells under the scirrhous gastric cancer microenvironment and promote peritoneal carcinomatosis in vitro and in vivo. Mol. Cell. Biochem. 377, 177\u2013185 (2013).","journal-title":"Mol. Cell. Biochem."},{"key":"928_CR30","volume":"16","author":"F Wei","year":"2017","unstructured":"Wei, F. et al. Exosomes derived from gemcitabine-resistant cells transfer malignant phenotypic traits via delivery of miRNA-222-3p. Mol. Cancer 16, 132 (2017).","journal-title":"Mol. Cancer"},{"key":"928_CR31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s12079-016-0338-6","volume":"10","author":"A Subramanian","year":"2016","unstructured":"Subramanian, A. et al. Exosomes in carcinogenesis: molecular palkis carry signals for the regulation of cancer progression and metastasis. J. Cell Commun. Signal 10, 241\u2013249 (2016).","journal-title":"J. Cell Commun. Signal"},{"key":"928_CR32","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/path.2759","volume":"222","author":"O Tchernitsa","year":"2010","unstructured":"Tchernitsa, O. et al. Systematic evaluation of the miRNA-ome and its downstream effects on mRNA expression identifies gastric cancer progression. J. Pathol. 222, 310\u2013319 (2010).","journal-title":"J. Pathol."},{"key":"928_CR33","volume":"5","author":"F Zhou","year":"2014","unstructured":"Zhou, F. et al. Nuclear receptor NR4A1 promotes breast cancer invasion and metastasis by activating TGF-beta signalling. Nat. Commun. 5, 3388 (2014).","journal-title":"Nat. Commun."},{"key":"928_CR34","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/neuonc\/nos074","volume":"14","author":"NM Teplyuk","year":"2012","unstructured":"Teplyuk, N. M. et al. MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity. Neuro. Oncol. 14, 689\u2013700 (2012).","journal-title":"Neuro. Oncol."},{"key":"928_CR35","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1373\/clinchem.2010.151845","volume":"57","author":"S Asaga","year":"2011","unstructured":"Asaga, S. et al. Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. Clin. Chem. 57, 84\u201391 (2011).","journal-title":"Clin. Chem."},{"key":"928_CR36","volume":"9","author":"T Fang","year":"2018","unstructured":"Fang, T. et al. Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer. Nat. Commun. 9, 191 (2018).","journal-title":"Nat. Commun."},{"key":"928_CR37","doi-asserted-by":"crossref","first-page":"42262","DOI":"10.18632\/oncotarget.15040","volume":"8","author":"M Wei","year":"2017","unstructured":"Wei, M. et al. Malignant ascites-derived exosomes promote proliferation and induce carcinoma-associated fibroblasts transition in peritoneal mesothelial cells. Oncotarget 8, 42262\u201342271 (2017).","journal-title":"Oncotarget"},{"key":"928_CR38","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1038\/sj.onc.1210856","volume":"27","author":"IA Asangani","year":"2008","unstructured":"Asangani, I. A. et al. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27, 2128\u20132136 (2008).","journal-title":"Oncogene"},{"key":"928_CR39","volume":"7","author":"J Yu","year":"2016","unstructured":"Yu, J. et al. MicroRNA-182 targets SMAD7 to potentiate TGFbeta-induced epithelial-mesenchymal transition and metastasis of cancer cells. Nat. Commun. 7, 13884 (2016).","journal-title":"Nat. Commun."},{"key":"928_CR40","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/39369","volume":"389","author":"A Nakao","year":"1997","unstructured":"Nakao, A. et al. Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature 389, 631\u2013635 (1997).","journal-title":"Nature"},{"key":"928_CR41","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S1097-2765(00)00134-9","volume":"6","author":"P Kavsak","year":"2000","unstructured":"Kavsak, P. et al. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol. Cell 6, 1365\u20131375 (2000).","journal-title":"Mol. Cell"},{"key":"928_CR42","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ki.1997.42","volume":"51","author":"JP Rougier","year":"1997","unstructured":"Rougier, J. P., Moullier, P., Piedagnel, R. & Ronco, P. M. Hyperosmolality suppresses but TGF beta 1 increases MMP9 in human peritoneal mesothelial cells. Kidney Int. 51, 337\u2013347 (1997).","journal-title":"Kidney Int."},{"key":"928_CR43","doi-asserted-by":"crossref","first-page":"762","DOI":"10.3389\/fphys.2017.00762","volume":"8","author":"Y Chu","year":"2017","unstructured":"Chu, Y. et al. Proinflammatory effect of high glucose concentrations on HMrSV5 cells via the autocrine effect of HMGB1. Front. Physiol. 8, 762 (2017).","journal-title":"Front. Physiol."},{"key":"928_CR44","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000430332","volume":"37","author":"L Zhang","year":"2015","unstructured":"Zhang, L. et al. Effects of astragaloside IV against the TGF-beta1-induced epithelial-to-mesenchymal transition in peritoneal mesothelial cells by promoting Smad 7 expression. Cell. Physiol. Biochem. 37, 43\u201354 (2015).","journal-title":"Cell. Physiol. Biochem."},{"key":"928_CR45","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1523-1755.1998.00955.x","volume":"54","author":"JP Rougier","year":"1998","unstructured":"Rougier, J. P., Guia, S., Hagege, J., Nguyen, G. & Ronco, P. M. PAI-1 secretion and matrix deposition in human peritoneal mesothelial cell cultures: transcriptional regulation by TGF-beta 1. Kidney Int. 54, 87\u201398 (1998).","journal-title":"Kidney Int."},{"key":"928_CR46","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10585-005-2893-8","volume":"22","author":"NA Alkhamesi","year":"2005","unstructured":"Alkhamesi, N. A., Ziprin, P., Pfistermuller, K., Peck, D. H. & Darzi, A. W. ICAM-1 mediated peritoneal carcinomatosis, a target for therapeutic intervention. Clin. Exp. Metastas-. 22, 449\u2013459 (2005).","journal-title":"Clin. Exp. Metastas-."},{"key":"928_CR47","doi-asserted-by":"crossref","first-page":"D812","DOI":"10.1093\/nar\/gku1073","volume":"43","author":"M Goldman","year":"2015","unstructured":"Goldman, M. et al. The UCSC cancer genomics browser: update 2015. Nucleic Acids Res. 43, D812\u2013D817 (2015).","journal-title":"Nucleic Acids Res."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0928-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0928-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0928-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T07:05:33Z","timestamp":1671519933000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0928-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,28]]},"references-count":47,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,9]]}},"alternative-id":["928"],"URL":"https:\/\/doi.org\/10.1038\/s41419-018-0928-8","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,28]]},"assertion":[{"value":"2 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2022","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Clarification","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Editor's Note: Concerns have been raised about the integrity of the data reported in this article. This is currently being investigated. Further editorial action may be taken as appropriate once the investigation into the concerns is complete and all parties have been given an opportunity to respond in full.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"854"}}